Beyond nanoparticle-based oral drug delivery: transporter-mediated absorption and disease targeting-Reference-Cited by-同舟云学术

Beyond nanoparticle-based oral drug delivery: transporter-mediated absorption and disease targeting

Published:2024 Issue:12 Volume:12 Page:3045-3067
ISSN:2047-4830
Container-title:Biomaterials Science
language:en
Short-container-title:Biomater. Sci.

Author:

Cho Hana¹^ORCID,Huh Kang Moo²^ORCID,Cho Hyun Ji¹^ORCID,Kim Bogeon¹,Shim Min Suk³^ORCID,Cho Yong-Yeon¹⁴^ORCID,Lee Joo Young¹⁴^ORCID,Lee Hye Suk¹⁴^ORCID,Kwon Young Jik⁵^ORCID,Kang Han Chang¹⁴^ORCID

Affiliation:

1. Department of Pharmacy, College of Pharmacy, The Catholic University of Korea, Bucheon, 14662, Republic of Korea

2. Department of Polymer Science and Engineering & Materials Science and Engineering, Chungnam National University, Daejeon 34134, Republic of Korea

3. Division of Bioengineering, Incheon National University, Incheon 22012, Republic of Korea

4. Regulated Cell Death (RCD) Control Material Research Institute, The Catholic University of Korea, Bucheon, 14662, Republic of Korea

5. Department of Pharmaceutical Sciences, University of California, Irvine, CA 92697, USA

Abstract

GI transporter/receptor-mediated nanosized drug delivery systems could improve oral absorption and further target organs or diseases for effective therapeutic outcomes.

Funder

National Research Foundation of Korea

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/BM/D4BM00313F

Reference100 articles.

1. Intestinal drug transporters in pathological states: an overview

2. Functional transformations of bile acid transporters induced by high-affinity macromolecules

3. Oral Nanoparticles Exhibit Specific High-Efficiency Intestinal Uptake and Lymphatic Transport

4. Expression and Regulation of Drug Transporters and Metabolizing Enzymes in the Human Gastrointestinal Tract

5. Regional Distribution of Solute Carrier mRNA Expression Along the Human Intestinal Tract